U.S. Physical Therapy (NYSE:USPH) Stock Rating Upgraded by Citizens Jmp

U.S. Physical Therapy (NYSE:USPHGet Free Report) was upgraded by stock analysts at Citizens Jmp to a “strong-buy” rating in a report released on Monday,Zacks.com reports.

A number of other research analysts have also issued reports on the company. JPMorgan Chase & Co. lifted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $100.00 to $115.00 in a research note on Monday. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday. They issued an “outperform” rating and a $113.00 target price on the stock. Finally, Barrington Research reiterated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $114.00.

Read Our Latest Stock Report on U.S. Physical Therapy

U.S. Physical Therapy Stock Down 0.6 %

Shares of NYSE:USPH opened at $94.98 on Monday. The firm has a market capitalization of $1.43 billion, a PE ratio of 101.04, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm’s 50-day moving average is $89.67 and its two-hundred day moving average is $89.85.

Insider Buying and Selling

In other news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. The trade was a 19.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This represents a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,412 shares of company stock worth $706,605 over the last 90 days. 1.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Canada Pension Plan Investment Board purchased a new stake in shares of U.S. Physical Therapy in the second quarter valued at about $28,000. Innealta Capital LLC purchased a new stake in U.S. Physical Therapy during the 2nd quarter valued at approximately $30,000. Quest Partners LLC lifted its position in U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares during the period. Quarry LP lifted its position in U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after acquiring an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $51,000.

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.